Rakuten Medical
To conquer cancer.
- Headquarters
- San Diego, California
- Founded
- 2010
- Business Model
- B2B
- Website
- rakuten-med.com
- Total Funding
- $535.0M
- Last Round
- $100.0M Series FJan 2026
- Rounds
- 4
About
Rakuten Medical, Inc. (formerly Aspyrian Therapeutics, Inc.) is a global biotechnology company developing and commercializing precision, cell-targeting photoimmunotherapy based on its proprietary Alluminox® platform. Founded in 2010 in San Diego, California, the company was rebranded from Aspyrian Therapeutics to Rakuten Medical in 2019. Alluminox therapies have been approved in Japan and the company is actively pursuing global approval. Rakuten Medical has offices in 5 countries including the United States, Japan, Taiwan, Switzerland, and India.
Summary
Rakuten Medical is a Biotech company based in San Diego, United States, founded in 2010. It has raised $535.0M in total across 4 rounds, most recently a $100.0M Series F round in Jan 2026. Investors include General Catalyst and Rakuten.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Jan 2026
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Create Free AccountInvestors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
BridgeBio makes targeted treatments for genetic diseases.